Children with cancer are being offered treatment plans tailored to their specific cancer thanks to a single genomic test that reads more than three billion letters of DNA to identify cancer-causing mutations.
A new study led by researchers at UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) and the Centre for Stem Cell Biology, University of Sheffield, has demonstrated the potential of stem cell therapy to treat those with Hirschsprung disease.
In a new partnership with Dame Kelly Holmes Trust, world class athlete mentors will support children and young people having treatment at Great Ormond Street Hospital.
After a detailed review process across the UK, the Tessa Jowell Brain Cancer Mission has announced that our joint GOSH/UCLH service has been designated as a Centre of Excellence.
The first-ever targeted treatment for brain tumours in children has been approved for NHS patients, following decades of research by a Great Ormond Street consultant.
A cheap and simple test, being developed with funding from the British Heart Foundation (BHF), will allow quick and safe monitoring in children with arrhythmogenic cardiomyopathies (ACM).
Great Ormond Street Hospital (GOSH) has announced plans to revolutionise how children living with a rare disease can gain access to life-changing treatments.
We're delighted to announce that Professor Dame Helen Cross and Professor Mark Peters have been named NIHR Senior Investigators in this year’s prestigious award list, making them among the most prominent and prestigious researchers funded by the NIHR.
To celebrate Rare Disease Day we invited patients and their families to try out 13 different hands-on and interactive fun and educational science and research activities for children and adults.